Whitebox Advisors’s AngioDynamics ANGO Stock Holding History

Whitebox Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-113,998	Closed	-$1.38M	–	92
2015 Q4	$1.38M	Buy	+113,998	New	+$1.4M	0.04%	142
2014 Q2	–	Sell	-133,060	Closed	-$2.1M	–	381
2014 Q1	$2.1M	Buy	133,060 +85,887	+182%	+$1.4M	0.09%	174
2013 Q4	$811K	Buy	+47,173	New	+$726K	0.04%	296

Other funds holding ANGO

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Whitebox Advisors's ANGO Position: Q1 2016 in Review

Whitebox Advisors sold out of AngioDynamics (ANGO) in Q1 2016, closing a stake of 113,998 shares — an estimated $1.38M sold.

Whitebox Advisors first reported a position in ANGO in Q4 2013 and held it in 3 quarters. The position peaked at $2.1M in Q1 2014. 121 funds tracked by Wall St. Rank hold ANGO as of Q1 2016.

Whitebox Advisors reported no remaining AngioDynamics position as of Q1 2016 after selling out during the quarter.
Whitebox Advisors sold 113,998 AngioDynamics shares in Q1 2016, an estimated $1.38M.
Whitebox Advisors first reported a position in AngioDynamics in Q4 2013 and held it in 3 quarters.
Whitebox Advisors's AngioDynamics position peaked at $2.1M in Q1 2014.
121 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2016.

Based on Whitebox Advisors's 13F filing for Q1 2016, filed 3 May 2016.